Closed · CDC-RFA-GH21-2173 · CFDA 93.318 · Discretionary

Capacity Building and Strengthening of Hospital Infection Control to detect, prevent and respond to antimicrobial resistance in India

Federal grant opportunity posted by Centers for Disease Control - CGH, cataloged on Grants.gov.

Varies
Award range
Closed
Status
July 20, 2021
Close date
1
Expected awards

The verdict

Capacity Building and Strengthening of Hospital Infection Control to detect, prevent and respond to antimicrobial resistance in India is a closed discretionary listing from Centers for Disease Control - CGH that offered Varies by applicant across 1 expected award. Future funding cycles may be published under the same CFDA number.

Varies
award range
Closed
application status
1
expected award
93.318
CFDA program

Opportunity snapshot. This Grants.gov announcement - Capacity Building and Strengthening of Hospital Infection Control to detect, prevent and respond to antimicrobial resistance in India - is cataloged under number CDC-RFA-GH21-2173 and tied to CFDA assistance listing 93.318, posted by Centers for Disease Control - CGH. Grants.gov currently shows the opportunity as closed, first posted on May 18, 2021. The funding category is Discretionary, delivered as a cooperative agreement.

Award economics. The award range on file is Varies by applicant. The agency has projected $205.0 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $205.0 million estimated pool, the average award works out to roughly $205.0 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on July 20, 2021. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

Varies by applicant

Close Date

July 20, 2021

Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.

Posted

May 18, 2021

Est. Total Funding

$205,000,000

Expected Awards

1

Instrument

Cooperative Agreement

Description

Antimicrobial resistance (AMR) is a global patient safety and public health concern. Hospital acquired infections (HAI) lead to adverse outcomes and increased cost of treatment. Effective infection prevention and control (IPC) interventions can reduce HAIs. The Government of India has prioritized combating AMR. The All India Institute of Medical Science (AIIMS) at the direction of the Indian Council of Medical Research (ICMR) is directing the only standardized HAI surveillance network in India with 32 nodal centers in 22 states. Through this NOFO, AIIMS will work with CDC and ICMR to implement a step-wise, scalable approach to generate and report accurate HAI and AMR data. In the first year, sites will perform HAI surveillance, improve antimicrobial use and use data to target IPC activities. Short-term outcomes include develop a trained workforce; ensure standardization of surveillance; and strengthen IPC programs. The long-term objective is a sustainable AMR and HAI surveillance network that produces quality data to inform the development and implementation of evidence-based national policies on IPC, antimicrobial stewardship and HAI prevention. The Government of India has prioritized combating AMR. The All India Institute of Medical Science (AIIMS) at the direction of the Indian Council of Medical Research (ICMR) is directing the only standardized HAI surveillance network in India with 32 nodal centers in 22 states. Through this NOFO, AIIMS will work with CDC and ICMR to implement a step-wise, scalable approach to generate and report accurate HAI and AMR data. In the first year, sites will perform HAI surveillance, improve antimicrobial use and use data to target IPC activities. Short-term outcomes include develop a trained workforce; ensure standardization of surveillance; and strengthen IPC programs. The long-term objective is a sustainable AMR and HAI surveillance network that produces quality data to inform the development and implementation of evidence-based national policies on IPC, antimicrobial stewardship and HAI prevention.

Eligibility

Grants.gov lists this opportunity under eligibility category code 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Laura Shelby lks2@cdc.gov

Key Dates

Posted May 18, 2021
Close Date July 20, 2021
Archive Date August 19, 2021
Last Updated May 18, 2021

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Capacity Building and Strengthening of Hospital Infection Control to detect, prevent and respond to antimicrobial resistance in India", offered by Centers for Disease Control - CGH. It is associated with CFDA program 93.318. Antimicrobial resistance (AMR) is a global patient safety and public health concern. Hospital acquired infections (HAI) lead to adverse outcomes and increased cost of treatment. Effective infection pr...
Is this opportunity still open?
No, this opportunity is closed. It closed on July 20, 2021. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is Varies by applicant. Total estimated funding: $205,000,000. Expected number of awards: 1.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants